WaveMan
WaveMan · Company
BDSX · Biodesix Inc
> Search tickers & screens ⌘K
LIVE
← All companies

BDSX Biodesix (BDSX) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-medical laboratories · CIK 0001439725
Quote by TradingView
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
25
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · no price filed

What the filings say about BDSX

Insiders, 180 days
+$1.0M net bought
1 buyer

Biodesix insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, BIODESIX INC insiders bought a net $1.0M of stock across 205 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
SCHULER JACK W
BUY
2026-08-13 SECtraded 2026-08-12
15,000
$367.0K
-11.4%
Context
  • 41 earlier Form 4 trades (code P or S) here by this insider (41 buys), the last on Aug 11, 2026.
  • +2.3% median (+3.8% mean) 90-day return after 28 previous buys.
  • The trade is 2.7% of the 555,810 shares held after it.
  • No other insider bought within 30 days.
  • 25 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider SCHULER JACK W bought about $367.0K of BDSX on Aug 12, 2026; 25 funds added in the latest 13F quarter.
SCHULER JACK W
BUY
2026-08-12 SECtraded 2026-08-11
13,700
$328.9K
-10.6%
Context
  • 40 earlier Form 4 trades (code P or S) here by this insider (40 buys), the last on Aug 10, 2026.
  • +4.3% median (+6.3% mean) 90-day return after 29 previous buys.
  • The trade is 2.5% of the 540,810 shares held after it.
  • No other insider bought within 30 days.
  • 25 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider SCHULER JACK W bought about $328.9K of BDSX on Aug 11, 2026; 25 funds added in the latest 13F quarter.
SCHULER JACK W
BUY
2026-08-12 SECtraded 2026-08-10
13,900
$337.0K
-10.6%
Context
  • 39 earlier Form 4 trades (code P or S) here by this insider (39 buys), the last on Jan 26, 2026.
  • +2.3% median (+5.7% mean) 90-day return after 30 previous buys.
  • The trade is 2.6% of the 527,110 shares held after it.
  • No other insider bought within 30 days.
  • 25 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider SCHULER JACK W bought about $337.0K of BDSX on Aug 10, 2026; 25 funds added in the latest 13F quarter.
Hutton Scott
President & CEO
SELL
2026-02-23 SEC
1,490
$19.0K
+63.3%
Context
  • 26 earlier Form 4 trades (code P or S) here by this insider (1 buy, 25 sales), the last on Feb 10, 2026.
  • The trade is 3.1% of the 48,767 shares held after it.
  • 4 other insiders sold within 30 days.
  • 25 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Hutton Scott sold about $19.0K of BDSX on Feb 23, 2026; 4 other insiders sold within 30 days and 25 funds added in the latest 13F quarter.
Vazquez Chris
Chief Accounting Officer
SELL
2026-02-23 SEC
211
$2.7K
+63.3%
Context
  • 18 earlier Form 4 trades (code P or S) here by this insider (18 sales), the last on Feb 10, 2026.
  • The trade is 13.3% of the 1,586 shares held after it.
  • 4 other insiders sold within 30 days.
  • 25 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Vazquez Chris sold about $2.7K of BDSX on Feb 23, 2026; 4 other insiders sold within 30 days and 25 funds added in the latest 13F quarter.
205 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 200 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$1.0M over 180 days
+$1.0M over 90 days · +$1.0M of it by a 10%+ holder
more than 92% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
25 funds bought in last quarter
below 81% of Healthcare Services
Revenue
+24.1% year over year
more than 74% of Healthcare Services
Margin
-39.8% net margin
below 84% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
4.1% of the float short (float per yahoo 2026-10-26) · 1.8 days to cover · settled 2026-09-30
below 67% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch BDSX

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+254.3%12M
-9%+131%+270%+410%2025-102025-122026-022026-042026-062026-082026-10 2026-01-23 · SCHULER JACK W bought $944.8K2026-01-22 · SCHULER JACK W bought $903.8K2026-08-12 · SCHULER JACK W bought $367.0K2026-08-10 · SCHULER JACK W bought $337.0K2026-08-11 · SCHULER JACK W bought $328.9K2026-01-26 · SCHULER JACK W bought $236.0K2026-02-10 · Hutton Scott sold $35.9K2026-02-23 · Hutton Scott sold $19.0K2026-02-10 · Cowie Robin Harper sold $9.5K2026-01-16 · Hutton Scott sold $7.9K2026-02-23 · Pestano Gary Anthony sold $7.1K2026-02-23 · O'Kane Kieran sold $6.8K2026-02-23 · Cowie Robin Harper sold $6.8K2026-02-10 · O'Kane Kieran sold $5.9K2026-02-10 · Pestano Gary Anthony sold $5.4K2026-02-23 · Vazquez Chris sold $2.7K2026-01-16 · Pestano Gary Anthony sold $2.4K2026-01-16 · O'Kane Kieran sold $2.4K2026-01-16 · Cowie Robin Harper sold $2.4K2025-11-10 · Hutton Scott sold $1.4K2026-02-10 · Vazquez Chris sold $1.0K2026-01-16 · Vazquez Chris sold $6762025-11-10 · Cowie Robin Harper sold $3812025-11-10 · O'Kane Kieran sold $1902025-11-10 · Pestano Gary Anthony sold $1752025-11-10 · Vazquez Chris sold $99
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns BDSX: institutional holders (13F)

13F holdings, latest reported quarter
AIGH Capital Management LLC
678,328 sh
$15.3M
Soleus Capital Management, L.P.
585,958 sh
$13.2M
Telemark Asset Management, LLC
489,824 sh
$11.0M
Aberdeen Group plc
388,639 sh
$8.8M
Birchview Capital, LP
286,804 sh
$6.5M

Congress trades in BDSX

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

BDSX planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

BDSX mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
1290 Essex Small Cap Growth Fund
$1.2M position · as of 2026-07-31
1.1%
Ultra-Small Company Fund
$338.2K position · as of 2026-06-30
0.3%
Ultra-Small Company Market Fund
$225.5K position · as of 2026-06-30
0.2%
iShares Micro-Cap ETF
$392.5K position · as of 2026-06-30
0.0%
1290 VT Micro Cap Portfolio
$26.1K position · as of 2026-06-30
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$1.6M position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Hutton
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.2M
$666.3K
$984.6K
-82%
n/a
2024
$2.1M
$1.7M
$888.1K
-17%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $1.0M bought by insiders over 180 days, 25 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABLLN

BDSX financials

Revenue growth
+24.1%
XBRL, annual
Net margin
-39.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$102.9M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-27.0%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$20.2M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
5.47x
long-term debt only, 2026-06-30; equity 2026-06-30
Cash flow to debt
-0.40x
TTM operating cash flow over long-term debt only, 2026-06-30
Return on equity
-540.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-30.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-27.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$244.3M
market value at close 2026-10-26 on 2026-07-30 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
FCF yield
-9.0%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$88.5M$71.3M$49.1M$38.2M
Operating income-$27.9M-$34.5M-$41.3M-$50.6M
Net income-$35.3M-$42.9M-$52.1M-$65.4M
EPS (diluted)-4.67-6.64-0.64-1.55
Operating cash flow-$23.3M-$48.6M-$22.9M-$45.0M
Cash$19.0M$26.2M$26.3M$43.1M
Long-term debt$50.0M$40.0M$40.1M$30.1M
SEC XBRL, fiscal years, as known on 2026-10-27

BDSX Stock Sonar score 6/7 axes

Find similar shapesCompare

BDSX ranks highest on insider conviction (78th percentile) and growth (74th), and lowest on financial health (15th), among Healthcare Services peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
18
Inputs
  • Return on equity-540.1% · 6 pct, sector of 70
  • Return on assets-30.3% · 26 pct, sector of 88
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-27.0% · 21 pct, sector of 68
Financial health
15
Inputs
  • Debt to equity5.47x · 2 pct, sector of 61
  • Cash flow to debt-0.40x · 28 pct, sector of 66
Growth
74
Inputs
  • Revenue growth, YoY+24.1% · 74 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
78
Inputs
  • Net Form 4 buying (codes P and S), 180d$1.0M · 92 pct, sector of 64
  • Insider buyers, 180d1 · 63 pct, sector of 64
Institutional and government
19
Inputs
  • Funds adding, latest quarter25 · 19 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$120K · 19 pct, universe of 1,063
Risk and compliance
67
Inputs
  • Short interest, % of float+4.1% · 55 pct, sector of 95
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+6.6% · 79 pct, sector of 72
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

BDSX filings, in plain words

Are Biodesix insiders buying or selling BDSX?

In the 180 days to 2026-10-27, Biodesix insiders were net buyers, a net $1.0M across purchases and sales reported on Form 4, by 1 buyer.

Read the full summary

In the 180 days to 2026-10-27, Biodesix insiders were net buyers of BDSX, a net $1.0M across purchases and sales reported on Form 4 by 1 buyer. Most of that figure, $1.0M, came from a holder of 10% or more rather than an officer or director. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies